Although significant progress has been made in identifying changes in the glycosylation patterns of some proteoforms, obtaining inadequate amounts of PSA glycoforms for separation and detection has limited its clinical use in the screening and diagnosis of prostate cancer [236]. This evidence concerns the gene KLK3 and prostate cancer.